Tuesday, September 26, 2023
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Cuba’s achievement with Covid-19 vaccine makes headlines in France

Paris, Jun 20 (Prensa Latina) French media on Sunday highlighted a new scientific achievement by Cuba, as the efficacy of its Covid-19 vaccine candidate Soberana 02 is above the parameter set by the World Health Organization (WHO).

On Saturday, Vicente Verez Bencomo, general director of the Finlay Vaccines Institute in Havana, informed that an independent committee determined a 62-percent efficacy of the Cuban vaccine candidate, which exceeds the 50 percent established by WHO to become a vaccine, a success Cuban President Miguel Diaz-Canel highlighted on social media.

France Info, LCI and France 24, as well as Le Parisien newspaper, echoed the result after 13 months of work in Cuba on a vaccine candidate that is expected to protect the country’s entire population from Covid-19 before the end of this year.

Likewise, those media outlets quoted statements in which Verez said that the positive impact of the vaccine candidate Soberana 02 was determined in relation to the administration of two doses, so it is very likely that it increases by adding a third immune booster shot with Soberana Plus.

France Info recalled that the Cuban vaccine candidate Abdala is also in the third and final phase of clinical trials in humans. Cuba has developed five vaccine candidates so far.

France 24 published that more than four million doses have already been administrated in emergency health interventions in Havana and other Cuban provinces.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.